We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Genital Warts Decline Thanks to HPV Vaccine

By HospiMedica International staff writers
Posted on 29 Apr 2013
A new study reveals that the incidence of genital warts declined by more than 90% in adolescent and teenage girls following the introduction of the human papillomavirus (HPV) vaccine in Australia.

Researchers at the University of New South Wales (Sydney, Australia), the University of Melbourne (Australia), and other institutions conducted a trend analysis study of surveillance data involving 85,770 Australian born patients to measure the effect on genital warts of the national HPV vaccination program in Australia, which started in mid-2007. More...
Data were collated from eight sexual health services from 2004 to 2011, with the two largest clinics also collecting self-reported HPV vaccination status from 2009. The main outcome measure was trends in proportion of new patients diagnosed as having genital warts.

The results showed that large declines occurred in the proportions of women diagnosed as having genital warts in the vaccination period—from 11.5% in 2007 to 0.85% in 2011 in women under 21, and from 11.3% in 2007 to 3.1% in 2011 in women 21–30; no significant decline in wart diagnoses was seen in women over 30 years of age. Significant declines also occurred in proportions of under 21 year old and 21–30 year old heterosexual men diagnosed as having genital warts; again, no significant decline in genital wart diagnoses was seen in heterosexual men over 30 years of age. Significantly, in 2011 no genital wart diagnoses were made among 235 women under 21 years of age who reported prior HPV vaccination. The study was published in April 18, 2013, in BMJ.

“The significant declines in the proportion of young women found to have genital warts and the absence of genital warts in vaccinated women in 2011 suggests that the human papillomavirus vaccine has high efficacy outside the trial setting,” concluded lead author Basil Donovan, MD, of the University of New South Wales, and colleagues. “Large declines in diagnoses of genital warts in heterosexual men are probably due to herd immunity.”

In 2007 Australia became one of the first countries to implement a nationally funded program of HPV vaccination, offering free vaccination to girls aged 12–13 years in schools. In addition, from 2007 to 2009 two catch-up programs were implemented, one for 13–18 year old schoolgirls and the other for 18–26 year old women in the community. The quadrivalent vaccine provides protection against HPV types 6 and 11, which cause genital warts, in addition to the cancer causing types 16 and 18.

Related Links:

University of New South Wales
University of Melbourne



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.